Form 4 for FLGT Fulgent Genetics, Inc.
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-05 · accession 0000950170-25-033994 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 | 2025-03-05 | FLGT | Kim Paul | CFO, Treas | P - Purchase | $15.96 | +100.0K | 348.3K | +40% | +$1.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | P | A | 100,000 | $15.96 | 348,282 | D | — | — | (F1) The shares were purchased in multiple transactions ranging from $15.48 to $16.60, inclusive. The reported price is the weighted-average purchase price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |